High-Throughput Cytometry for MSC Identity & Differentiation

Accurate assessment of mesenchymal stem cell (MSC) identity and differentiation is essential in both research and clinical applications—especially in the fast-moving field of regenerative medicine. MSCs are multipotent adult stem cells with the capacity to self-renew and differentiate into various cell types, including osteoblasts, chondrocytes, and adipocytes—making them vital for tissue engineering, immune modulation, and cell-based therapies.

To ensure therapeutic efficacy, safety, and regulatory compliance, robust tools are needed to validate MSC phenotype and monitor changes over time. High-Throughput Screening (HTS) Cytometry offers a powerful solution by enabling precise, multiparametric analysis of MSC surface markers and differentiation status all in a scalable, efficient workflow.

Key Takeaways

This application note demonstrates how Sartorius’ iQue® High Throughput Cytometry platform empowers researchers to:

• Confidently verify MSC identity through rapid, multiparametric surface marker profiling.
• Detect and quantify senescence to ensure functional cell integrity across passages.
• Monitor osteogenic and adipogenic differentiation in real time, enabling earlier, more accurate lineage confirmation.
• Enhance quality control with consistent, reproducible data across batches and experimental conditions.

The result: faster workflows, better data quality, and enhanced confidence in MSC-based research and therapeutic applications.